Skip to Content

C1 esterase inhibitor (human) Pregnancy and Breastfeeding Warnings

C1 esterase inhibitor (human) is also known as: Berinert, Cinryze, Haegarda

Medically reviewed on Jan 10, 2018

C1 esterase inhibitor (human) Pregnancy Warnings

Animal studies have failed to reveal evidence of teratogenicity. There are no controlled data in human pregnancy.

FDA pregnancy category: C

Use only if clearly needed and benefit outweighs potential risk.

See references

C1 esterase inhibitor (human) Breastfeeding Warnings

Caution is recommended

Excreted into human milk: Unknown
Excreted into animal milk: Unknown

The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Cinryze (complement C1 esterase inhibitor)." ViroPharma Incorporated, Exton, PA.

References for breastfeeding information

  1. "Product Information. Cinryze (complement C1 esterase inhibitor)." ViroPharma Incorporated, Exton, PA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide